河南东吉高科有限公司
细胞培养
| 人胰腺癌细胞–KP4-2 | DF12+10%FBS+1%P/S 贴壁 |
| 人脑部多形性成釉细胞瘤细胞–KS-1=KS1 | MEM+10%FBS+1%P/S 贴壁 |
| 人食管鳞状癌细胞–KYSE-270 断种 | 1640：F12=1:1+10%FBS+1%P/S 贴壁 |
| 人食管鳞状细胞癌细胞–KYSE-70 | 1640+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–LC-1-sq | 1640：F12=1:1+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–LC-1-sq-SF | 1640：F12=1:1+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–LC-1F | 1640：F12=1:1+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–LCAM1 | 1640+10%FBS+1%P/S 贴壁 |
| 人胃癌细胞–LMSU | F10+10%FBS+1%P/S 贴壁 |
| 人脑部多形性成釉细胞瘤细胞–LN-18 | DMEM+10%FBS+1%P/S 贴壁 |
| 人急性T细胞白血病细胞–J.RT3-T3.5 | 1640+10%FBS+1%P/S 悬浮 |
| 人多发性骨髓瘤细胞–LP-1 | IMDM+10%FBS+1%P/S 悬浮 |
| 人结肠癌细胞–LS123 | MEM+10%FBS+1%P/S 悬浮 |
| 人小细胞肺癌细胞–Lu-134-A | 1640+10%FBS+1%P/S 贴壁 |
| 人小细胞肺癌细胞–Lu-134-B | 1640+10%FBS+1%P/S 悬浮 |
| 人小细胞肺癌细胞–Lu-135 | 1640+10%FBS+1%P/S 悬浮 |
| 人小细胞肺癌细胞–Lu-139 | 1640+10%FBS+1%P/S 悬浮 |
| 人小细胞肺癌细胞–Lu-140 | 1640+10%FBS+1%P/S 悬浮 |
| 人小细胞肺癌细胞–Lu-143 | 1640+10%FBS+1%P/S 悬浮 |
| 人小细胞肺癌细胞–Lu-24 | 1640+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–LU65 | 1640+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–LU65A | 1640+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–LU65B | 1640+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–LU65C | 1640+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–LU99 | 1640+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–LU99A | 1640+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–LU99B | 1640+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–LU99C | 1640+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–LXF-289 | 1640+10%FBS+1%P/S 贴壁 |
| 人脑部多形性成釉细胞瘤细胞–M059J | DF12+15 mM HEPES+2.5 mM谷氨酰胺+0.5 mM和1.2 g/L碳酸氢钠+10%FBS+1%P/S 贴壁 |
| 人黑色素瘤细胞–M14 | 1640+10%FBS+1%P/S 贴壁 |
| 人黑素瘤细胞–Malme-3M | IMDM+20%FBS+1%P/S 贴壁 |
| 人淋巴癌细胞–MC116 | 1640+20%FBS+1%P/S 悬浮 |
| 人卵巢癌细胞–MCAS | MEM+10%FBS+1%P/S 贴壁 |
| 人结肠癌细胞–KM12SM | DMEM+10%FBS+1%P/S 贴壁 |
| – | DMEM+10%FBS+1%P/S 半贴 |
| 人结肠癌细胞–MDST8 | DMEM+10%FBS+1%P/S 贴壁 |
| 人子宫癌细胞–MES-SA-Dx5 | MACOY’S5A+10%FBS+1%P/S 贴壁 |
| 人肉瘤细胞–MFH-ino | DF12+10%FBS+1%P/S 贴壁 |
| 人尤文氏肉瘤细胞–MHH-ES1 | 1640+10%FBS+1%P/S 贴壁 |
| 人淋巴癌细胞–MLMA | 1640+10%FBS+1%P/S 悬浮 |
| 人脑部多形性成釉细胞瘤细胞–MOG-G-CCM | F10+DMEM+10%FBS+1%P/S 贴壁 |
| 人脑部多形性成釉细胞瘤细胞–MOG-G-UVW | F10+DMEM+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–MOR-CPR | 1640+10%FBS+1%P/S 悬浮 |
| 人间皮瘤细胞–MPP-89 | F10+15%FBS+1%P/S 贴壁 |
| 人小细胞肺癌细胞–MS-1-L | 1640+10%FBS+1%P/S 悬浮 |
| 人乳腺癌细胞–MX-1 | DF12+10%FBS+1%P/S 贴壁 |
| 人神经母细胞瘤细胞–NB16 | 1640+15%FBS+1%P/S 悬浮 |
| 人小细胞肺癌细胞–NCI-H1092 | DF12+0.005 mg/ml 胰岛素 + 0.01g/ml Transferrin+30nM Sodium selenite + 10 nM 氢化可的松 + 10 nM beta-estradiol + extra 2mM 谷氨酰胺 + 5%FBS |
| 人小细胞肺癌细胞–NCI-H1105 | DF12 + 0.005 mg/ml 胰岛素 + 0.01g/ml Transferrin+30nM Sodium selenite + 10 nM 氢化可的松 + 10 nM beta-estradiol + extra 2mM 谷氨酰胺 + 5%FBS |
| 人非小细胞肺癌细胞–NCI-H1155 | 1640+10%FBS+1%P/S 贴壁 |
| 人小细胞肺癌细胞–NCI-H1184 | DF12+ 0.02 mg/ml 胰岛素 + 0.01 mg/ml transferrin + 25 nM sodium selenite + 50 nM 氢化可的松 + 1 ng/ml Epidermal Growth Factor + 0.01 mM ethanolamine + 0.01 mM phosphorylethanolamine + 100 pM triiodothyronine + 0.5% (w/v) bovine serum albumin + 10 mM HEPES + 0.5 mM sodium pyruvate + 2mM 谷氨酰胺 + 10%FBS 悬浮 |
| 人小细胞肺癌细胞–NCI-H1341 | DF12+ 0.02 mg/ml 胰岛素 + 0.01 mg/ml transferrin + 25 nM sodium selenite + 50 nM 氢化可的松 + 1 ng/ml Epidermal Growth Factor + 0.01 mM ethanolamine + 0.01 mM phosphorylethanolamine + 100 pM triiodothyronine + 0.5% (w/v) bovine serum albumin + 10 mM HEPES + 0.5 mM sodium pyruvate + 2mM 谷氨酰胺 + 10%FBS 悬浮 |
| 人肺腺癌细胞 stage 4–NCI-H1355 | DF12+ 0.02 mg/ml 胰岛素 + 0.01 mg/ml transferrin + 25 nM sodium selenite + 50 nM 氢化可的松 + 1 ng/ml Epidermal Growth Factor + 0.01 mM ethanolamine + 0.01 mM phosphorylethanolamine + 100 pM triiodothyronine + 0.5% (w/v) bovine serum albumin + 10 mM HEPES + 0.5 mM sodium pyruvate + 2mM 谷氨酰胺 + 10%FBS 悬浮 |
| 人肺腺癌细胞–NCI-H1435 | 1640+10%FBS+1%P/S 贴壁 |
| 人肺癌腺癌细胞stage4–NCI-H1573 | 1640+10%FBS+1%P/S 贴壁 |
| 人小细胞肺癌细胞–NCI-H1618 | DF12 + 0.005 mg/ml 胰岛素 + 0.01 mg/ml Transferrin + 30nM Sodium selenite (final conc.) + 10 nM 氢化可的松 (final conc.) + 10 nM beta-estradiol (final conc.) + extra 2mM 谷氨酰胺 (for final conc. of 4.5 mM) + 5% fetal bovine serum + 5%FBS悬浮 |
| 人非小细胞肺癌细胞系–NCI-H1651 | DF12+10%FBS+1%P/S 贴壁 |
| 人小细胞肺癌细胞–NCI-H1672 | DF12+5%FBS+1%P/S 悬浮 |
| 人非小细胞肺癌细胞–NCI-H1693 | 1640+10%FBS+1%P/S 贴壁 |
| 人小细胞肺癌细胞–NCI-H1694 | DF12+ 0.005 mg/mL 胰岛素+0.01 mg/mL Transferrin+30nM Sodium selenite (final conc.)+10 nM 氢化可的松 (final conc.)+10 nM beta-estradiol (final conc.)+extra 2mM 谷氨酰胺 (for final conc. of 4.5 mM)+5%FBS 悬浮 |
| 人非小细胞肺癌细胞–NCI-H1770 | 1640+10%FBS+1%P/S 贴壁 |
| 人小细胞肺癌细胞–NCI-H1836 | DF12 + 0.005 mg/ml 胰岛素 + 0.01 mg/ml Transferrin + 30nM Sodium selenite+ 10 nM 氢化可的松 + 10 nM beta-estradiol + 5%FBS+1%P/S 悬浮 |
| 人非小细胞肺癌细胞–NCI-H2023 | DF12+ 0.005 mg/mL 胰岛素+0.01 mg/mL Transferrin+30nM Sodium selenite (final conc.)+10 nM 氢化可的松 (final conc.)+10 nM beta-estradiol (final conc.)+extra 2mM 谷氨酰胺 (for final conc. of 4.5 mM)+5%FBS 贴壁 |
| 人小细胞肺癌细胞–NCI-H2081 | DF12+ 0.005 mg/mL 胰岛素+0.01 mg/mL Transferrin+30nM Sodium selenite (final conc.)+10 nM 氢化可的松 (final conc.)+10 nM beta-estradiol (final conc.)+extra 2mM 谷氨酰胺 (for final conc. of 4.5 mM)+5%FBS 悬浮 |
| 人非小细胞肺癌细胞–NCI-H2106 | DF12+ 0.005 mg/mL 胰岛素+0.01 mg/mL Transferrin+30nM Sodium selenite (final conc.)+10 nM 氢化可的松 (final conc.)+10 nM beta-estradiol (final conc.)+extra 2mM 谷氨酰胺 (for final conc. of 4.5 mM)+5%FBS 悬浮 |
| 人非小细胞肺癌细胞–NCI-H2405 | 1640+10%FBS+1%P/S 贴壁 |
| 人非小细胞肺癌细胞–NCI-H2444 | 1640+10%FBS+1%P/S 贴壁 |
| 人间皮瘤细胞–NCI-H28 | 1640+10%FBS+1%P/S 贴壁 |
| 人小细胞肺癌细胞–NCI-H345 | DF12 + 0.005mg/ml 胰岛素 + 0.01 mg/ml Transferrin + 30 nM Sodium selenite +10 nM 氢化可的松+10 nM beta-estradiol+2 mM 谷氨酰胺 Solution + 10% FBS 悬浮的多细胞聚集物和少部分贴壁生 |
| 人小细胞肺癌细胞–NCI-H510 | F12K+10%FBS+1%P/S 贴壁+悬浮 |
| 人小细胞肺癌细胞–NCI-H720 | DF12 + 0.005 mg/ml 胰岛素 + 0.01 mg/ml Transferrin + 30nM Sodium selenite (final conc.) + 10 nM 氢化可的松 (final conc.) + 10 nM beta-estradiol (final conc.) + extra 2mM 谷氨酰胺 (for final conc. of 4.5 mM) + 5% fetal bovine serum + 5%FBS悬浮 |
| 人小细胞肺癌细胞–NCI-H740 | 1640+10%FBS+1%P/S 悬浮 |
| 人小细胞肺癌细胞–NCI-H774 | DF12+10%FBS+1%P/S 悬浮 |
| 人非小细胞肺癌细胞–NCI-H835 | 1640+10%FBS+1%P/S 悬浮 |
| 人小细胞肺癌细胞–NCI-H841 | DF12 + 0.005mg/ml 胰岛素 + 0.01 mg/ml Transferrin + 30 nM Sodium selenite +10 nM 氢化可的松+10 nM beta-estradiol+2 mM 谷氨酰胺 Solution + 10% FBS 混合生长 |
| 人结肠癌细胞–NCI-H854 | 1640+10%FBS+1%P/S 悬浮 |
| 人小细胞肺癌细胞–NCI-H865 | 1640+10%FBS+1%P/S 悬浮 |
| 人非小细胞肺癌细胞–NCI-H920 | 1640+10%FBS+1%P/S 贴壁+悬浮 |
| 人黑素瘤细胞–NM2C5 | DMEM+10%FBS+1%P/S 贴壁 |
| 人卵巢癌细胞–OAW-42 | DMEM+10%FBS+1%P/S 贴壁 |
| 人乳腺癌细胞–OCUB-F | DMEM+10%FBS+1%P/S 贴壁 |
| 人乳腺癌细胞–OCUB-M | DMEM(低糖）+10%FBS+0.5mM+1%P/S 贴壁 |
| 人食管鳞状细胞癌细胞–OE-21 | 1640+10%FBS+1%P/S 贴壁 |
| 人宫颈鳞状细胞癌–OMC-1 | F12+10%（NBS）+1%P/S 贴壁 |
| 人结肠癌细胞–OUMS-23 | DMEM+10%FBS+1%P/S 贴壁 |
| 人卵巢癌细胞–OV56 | DF12+10%FBS+1%P/S 贴壁 |
| 人卵巢癌细胞–OV7 | DF12+10%FBS+1%P/S 贴壁 |
| 人卵巢癌细胞–OVK18 | MEM+10%FBS+1%P/S 贴壁 |
| 人卵巢癌细胞–OVKATE | 1640+10%FBS+1%P/S 贴壁 |
| 人卵巢癌细胞–OVMANA | 1640+10%FBS+1%P/S 贴壁 |
| 人卵巢癌细胞–OVSAHO | 1640+10%FBS+1%P/S 贴壁 |
| 人卵巢癌细胞–OVTOKO | 1640+10%FBS+1%P/S 贴壁 |
| 人白血病细胞–P116 | 1640+10%FBS+1%P/S 悬浮 |
| 人白血病细胞–P30-OHK | 1640+10%FBS+1%P/S 悬浮 |
| 人白血病细胞–P31-FUJ | 1640+10%FBS+1%P/S 悬浮 |
| 人胰腺癌细胞–Panc02.03 | 1640+10%FBS+10 U/ml 重组人胰岛素+1%P/S 贴壁 |
| 人胰腺癌细胞–Panc02.13 | 1640+10%FBS+ 10 Units/ml human recombinant 胰岛素+1%P/S 贴壁 |
| 人脑部多形性成釉细胞瘤细胞–SNU-1105 | DMEM+10%FBS+1%P/S 贴壁 |
| 人前列腺癌细胞–PC-3-nKR | 1640+10%FBS+1%P/S 贴壁 |